Close

Moleculin Biotech (MBRX) Advances WP1122 into Preclinical Stage

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. MSFT
5. LRCX
6. IBM
7. SPY
8. INTC
9. SNAP
10. BA


Go back to Moleculin Biotech (MBRX) Advances WP1122 into Preclinical Stage
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 4.31 -0.04 (0.92%)
Previous Close $4.35    52 Week High $9.58 
Open $4.30    52 Week Low $2.34 
Day High $4.50    P/E N/A 
Day Low $4.28    EPS $-0.34 
Volume 22,596